Clinical characteristics and economic impact of acute hospitalisations due to bronchiectasis exacerbations among adult Indigenous Australians in the Top End Northern Territory

Thomas Berhane, Anna Louise Bayfield, Timothy Howarth, Karlie James, Aruna Muthumala, Lin Mo, Kaspar Willson, Subash S. Heraganahally

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
2 Downloads (Pure)

Abstract

This cross-sectional study assessed the clinical and economic costs (Inpatient Activity Database) associated with hospitalisations due to bronchiectasis exacerbations among adult indigenous patients in the Top End, Northern Territory. Twenty case episodes from 15 indigenous patients with a mean age of 51.8 ± 12.7 years were recorded in a 3-month study window. The estimated cost was AUD 400 579.9, with cost per patient AUD 26 705 over 3 months and average cost per admission AUD 20 029. Extrapolating cost data across a 10-year period gave a conservative estimate of AUD 28 million.

Original languageEnglish
Pages (from-to)526-529
Number of pages4
JournalInternal Medicine Journal
Volume55
Issue number3
DOIs
Publication statusPublished - Mar 2025

Fingerprint

Dive into the research topics of 'Clinical characteristics and economic impact of acute hospitalisations due to bronchiectasis exacerbations among adult Indigenous Australians in the Top End Northern Territory'. Together they form a unique fingerprint.

Cite this